ARKG (ゲノム革命)
ARKG内の企業は、ゲノミクスの技術的および科学的発展と進歩をビジネスに組み込むことにより、人間と他の生活の質を拡張および強化することに焦点を当てており、実質的に利益を得ることが期待されています。 ARKGに所属する企業は、以下を開発、生産、または可能にすることができます。
- CRISPR
- ターゲットを絞った治療法
- バイオインフォマティクス
- 分子診断
- 幹細胞
- 農業生物学
ARKGは、今後バイオテクノロジー業界で主要な事業活動を行っている発行体を含む、ヘルスケアセクターのあらゆる業界または業界グループの発行体に集中していきます。
ARKGポートフォリオ TOP30
| Weight Rank | Company | Ticker | Quote ($) | Weight | Market Cap | Ark Ownership % | Market Value |
|---|---|---|---|---|---|---|---|
| 1 |  Teladoc Health | TDOC | 157.48 | 6.86% | $24.33b | 2.54% | $617.48m |
| 2 |  Exact Sciences Corp. | EXAS | 125.01 | 5.32% | $21.45b | 2.23% | $478.82m |
| 3 |  CareDx | CDNA | 90.5 | 4.57% | $4.71b | 8.73% | $411.06m |
| 4 |  Pacific Biosciences | PACB | 29.51 | 4.28% | $5.85b | 6.58% | $385.08m |
| 5 |  Regeneron | REGN | 528.75 | 4.05% | $56.34b | 0.66% | $365.03m |
| 6 |  Fate Therapeutics | FATE | 89.97 | 3.92% | $8.46b | 4.17% | $353.04m |
| 7 |  Novartis | NVS | 93.59 | 3.85% | $209.59b | 0.16% | $346.33m |
| 8 |  Vertex Pharmaceuticals | VRTX | 194.8 | 3.57% | $50.43b | 0.64% | $321.53m |
| 9 |  Ionis Pharmaceuticals | IONS | 37.79 | 3.33% | $5.33b | 5.63% | $300.07m |
| 10 |  Twist Bioscience | TWST | 112.77 | 3.32% | $5.51b | 5.43% | $299.23m |
| 11 |  Accolade | ACCD | 53.19 | 3.1% | $3.12b | 8.94% | $279.12m |
| 12 |  Takeda Pharmaceutical Company | TAK | 17.13 | 3.06% | $53.69b | 0.51% | $275.55m |
| 13 |  Veeva Systems | VEEV | 303.9 | 2.86% | $46.47b | 0.61% | $257.83m |
| 14 |  Incyte Corporation | INCY | 82.64 | 2.62% | $18.17b | 1.30% | $236.09m |
| 15 |  Roche Holdings | RHHBY | 47.66 | 2.56% | $328.90b | 0.07% | $230.84m |
| 16 |  CRISPR Therapeutics | CRSP | 128.76 | 2.55% | $9.76b | 2.35% | $229.47m |
| 17 |  10x Genomics | TXG | 191.17 | 2.45% | $20.99b | 1.32% | $221.01m |
| 18 |  Schrödinger, Inc. | SDGR | 76.34 | 2.15% | $5.38b | 4.13% | $193.16m |
| 19 |  Castle Biosciences | CSTL | 71.86 | 2.01% | $1.80b | 10.06% | $181.21m |
| 20 |  Iovance Biotherapeutics | IOVA | 23.87 | 1.88% | $3.65b | 4.65% | $169.71m |
| 21 |  Adaptive Biotechnologies | ADPT | 39.14 | 1.84% | $5.49b | 3.02% | $165.59m |
| 22 |  Beam Therapeutics | BEAM | 91.96 | 1.76% | $5.75b | 2.75% | $158.24m |
| 23 |  Invitae Corporation | NVTA | 31.53 | 1.74% | $6.30b | 2.48% | $156.50m |
| 24 |  Berkeley Lights | BLI | 48.18 | 1.72% | $3.21b | 4.82% | $154.89m |
| 25 |  Intellia Therapeutics | NTLA | 88 | 1.58% | $6.00b | 2.37% | $141.98m |
| 26 |  Codexis | CDXS | 21.54 | 1.55% | $1.39b | 10.03% | $139.31m |
| 27 |  Bristol Myers Squibb | BMY | 67.29 | 1.38% | $150.25b | 0.08% | $123.98m |
| 28 |  Personalis | PSNL | 23.63 | 1.31% | $1.04b | 11.37% | $117.93m |
| 29 |  Signify Health | SGFY | 29.59 | 1.28% | $6.68b | 2.32% | $115.16m |
| 30 |  Pure Storage | PSTG | 19.55 | 1.27% | $5.54b | 2.06% | $113.93 |
ARKGポートフォリオ 31-59
| Weight Rank | Company | Ticker | Quote ($) | Weight | Market Cap | Ark Ownership % | Market Value |
|---|---|---|---|---|---|---|---|
| 31 |  1Life Healthcare | ONEM | 34.29 | 1.2% | $4.72b | 2.29% | $108.19m |
| 32 |  Butterfly Network | BFLY | 13.87 | 1.18% | $2.65b | 4.66% | $106.57m |
| 33 |  Arcturus Therapeutics | ARCT | 35.91 | 1.16% | $945.16m | 11.07% | $104.64m |
| 34 |  908 Devices | MASS | 43.58 | 1.15% | $1.19b | 8.71% | $103.63m |
| 35 |  UiPath | PATH | 69.8 | 1% | $35.52b | 0.30% | $90.40m |
| 36 |  Recursion Pharmaceuticals | RXRX | 33.16 | 0.85% | $5.58b | 1.45% | $76.42m |
| 37 |  Veracyte | VCYT | 37.25 | 0.82% | $2.50b | 2.94% | $73.65m |
| 38 |  Cellectis | CLLS | 15.8 | 0.79% | $676.47m | 10.48% | $71.25m |
| 40 |  Abbvie | ABBV | 115.4 | 0.68% | $203.82b | 0.03% | $61.03m |
| 39 |  Repare Therapeutics | RPTX | 32.76 | 0.68% | $1.21b | 5.07% | $61.45m |
| 41 |  NanoString Technologies | NSTG | 60.68 | 0.62% | $2.74b | 2.05% | $56.18m |
| 42 |  Sema4 | CMLF | 12.56 | 0.62% | $695.12m | 10.03% | $55.78m |
| 43 |  Seres Therapeutics | MCRB | 20.66 | 0.6% | $1.89b | 2.87% | $54.35m |
| 44 |  Editas Medicine | EDIT | 38.53 | 0.57% | $2.61b | 1.98% | $51.70m |
| 45 |  Sarepta Therapeutics | SRPT | 86.12 | 0.56% | $6.87b | 0.73% | $50.33m |
| 46 |  Zymergen | ZY | 45.35 | 0.54% | $4.55b | 1.06% | $48.25m |
| 47 |  Seer Inc. | SEER | 31.26 | 0.5% | $1.92b | 2.52% | $44.68m |
| 48 |  AquaBounty Technologies | AQB | 6.24 | 0.46% | $443.18m | 9.37% | $41.54m |
| 49 |  Cerus Corporation | CERS | 5.89 | 0.4% | $984.47m | 3.61% | $35.56m |
| 50 |  Compugen | CGEN | 8.51 | 0.4% | $712.18m | 5.06% | $36.05m |
| 52 |  Surface Oncology | SURF | 7.5 | 0.36% | $325.72m | 10.04% | $32.71m |
| 53 | Dynamics Special Purpose Corp. | DYNS | 10.04 | 0.23% | $295.83m | 8.52% | $20.28m |
| 54 |  Evogene | EVGN | 3.7 | 0.14% | $153.96m | 8.40% | $12.56m |
| 55 |  Dicerna Pharmaceuticals | DRNA | 38.04 | 0.13% | $2.93b | 0.41% | $12.09m |
| 56 |  SomaLogic | CMII | 12.93 | 0.13% | $446.09m | 3.04% | $11.92m |
| 57 |  Pluristem Therapeutics Inc. | PSTI | 4.34 | 0.05% | $137.75m | 3.06% | $4.22m |
| 58 |  Organovo | ONVO | 8.5 | 0.03% | $60.50m | 3.89% | $2.35m |
| 59 |  Guardant Health | GH | 123.77 | 0% | $12.52b | $96.02k |
